Wilson Sonsini Goodrich & Rosati advised ONI on the deal.ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop…
ONI’s $75 Million Series B Funding Round


Wilson Sonsini Goodrich & Rosati advised ONI on the deal.ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop…
…